- Switching to tenofovir alafenamide versus continued therapy in chronic hepatitis B patients who were treated with entecavir: A prospective, multicenter, randomized controlled study
Kosuke Sato et al, 2022, Medicine CrossRef - Non-Achievement of Alanine Aminotransferase Normalization Associated with the Risk of Hepatocellular Carcinoma during Nucleos(t)ide Analogue Therapies: A Multicenter Retrospective Study
Jun Inoue et al, 2022, Journal of Clinical Medicine CrossRef - A 28-year-old male patient with asymptomatic and multi-drug-resistant HBV infection: a case report
Syed Ayaz Kazmi et al, 2024, Egyptian Liver Journal CrossRef - Switching to Tenofovir Alafenamide Fumarate in Chronic Hepatitis B Patients Who Had Detectable HBV DNA during Treatment with Entecavir
Kosuke Sato et al, 2022, The Tohoku Journal of Experimental Medicine CrossRef - Impact of switching to tenofovir alafenamide fumarate in patients with entecavir-treated chronic hepatitis B
Takashi Kumada et al, 2021, European Journal of Gastroenterology & Hepatology CrossRef